David C. U'Prichard

David C. U'Prichard

Nessuna posizione attualmente
77 anni
Health Technology
Commercial Services
Finance

Profilo

Dr. David C.
U'Prichard
is Independent cat Audeo Oncology, Inc., a Director at Anesiva, Inc., Founding Partner at Druid BioVentures LLC, Chairman at Cyclacel Pharmaceuticals, Inc., Venture Partner & Senior Advisor at Red Abbey Venture Partners LLC, Chairman at Orca Pharmaceuticals Ltd. and President at Druid Consulting LLC.
He is on the Board of Directors at Audeo Oncology, Inc., iCeutica, Inc., Anesiva, Inc., Angstrom Pharmaceuticals, Inc., BioMotiv LLC, Iroko Pharmaceuticals LLC, Iroko Pharmaceuticals, Inc., Ocimum Bio Solutions (India) Ltd., Ocimum Biosolutions, Inc., International House of Philadelphia and The Wilma Theater, Inc. Dr. U'Prichard was previously employed as Independent Director by Life Technologies Corp., Chairman by Cyclacel Group Plc, Chairman by Oxagen Ltd., Chairman by Pennsylvania Biotechnology Association, Venture Partner by Apax Partners (UK) Ltd., Chief Executive Officer & Director by 3-Dimensional Pharmaceuticals, Inc., Chairman-Research & Development by Smithkline Beecham Pharmaceuticals (India) Ltd., Executive Vice President-Biomedical Research by ICI Pharmaceuticals, Director, EVP & Director-International Research by Zeneca Group Plc, Scientific Director & Senior Vice President by Nova Pharmaceutical Corp., an Associate Professor by Feinberg School of Medicine, Venture Partner by Care Capital LLC, Venture Partner by Apax Partners, Inc., and Non-Executive Director by Silence Therapeutics Plc.
He also served on the board at Alpharma, Inc., Invitrogen Corp., Biotechnology Industry Organization, Atugen AG, CoGenesys, Inc., Guilford Pharmaceuticals, Inc., Life Sciences Research, Inc., Lynx Therapeutics, Inc., Naurex, Inc., Ocimum Bio Solutions (India) Ltd., Predict, Inc. and SMART Biosciences, Inc. He received his undergraduate degree from the University of Glasgow and a doctorate degree from the University of Kansas.

Precedenti posizioni note di David C. U'Prichard

SocietàPosizioneFine
Churchill Pharmaceuticals
Direttore/Membro del Consiglio 02/09/2020
Direttore/Membro del Consiglio 02/09/2020
Direttore/Membro del Consiglio 02/09/2020
Direttore/Membro del Consiglio 02/09/2020
International House of Philadelphia
Direttore/Membro del Consiglio 02/09/2020
Vedi nel dettaglio l'esperienza di David C. U'Prichard

Formazione di David C. U'Prichard

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

76

Relazioni di 1° grado

49

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private49

Health Technology

Health Technology

Health Technology

Finance

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Technology Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Finance

Health Technology

Health Technology

Health Technology

Druid Consulting LLC

Commercial Services

Health Technology

Health Technology

Nova Pharmaceutical Corp.

Commercial Services

Health Technology

Commercial Services

International House of Philadelphia

Consumer Services

Consumer Services

Health Technology

Finance

Consumer Services

Technology Services

Finance

Churchill Pharmaceuticals

  1. Mercati
  2. Insiders
  3. David C. U'Prichard